Search Results 341-350 of 16184 for pharmacogenetics
D., is a laboratory geneticist, with specialty interest in hereditary cancer predisposition syndromes and rare diseases. His focus includes: Comprehensive ...
See educational opportunities and alumni in Nilufer Ertekin-Taner's Genetics of Alzheimer's Disease and Endophenotypes lab at Mayo Clinic.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
In this procedure, specialists aim to fix or replace a faulty gene to try to cure a disease or make the body better able to fight a disease.
About this study. This proposal is for a pilot study comparing volumes of 18F-DOPA-PET avidity with contrast enhancement and T2 FLAIR on MRI.
Itacitinib is an experimental drug with an excellent safety record and appears to have activity as a GVHD treatment. A new blood test can identify patients ...
The primary objectives for this study are: The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of ...
The purpose of this study is to evaluate olaparib and temozolomide in treating patients with uterine leiomyosarcoma (LMS) that has spread to other places of ...
Genetic testing can help you and your health care team understand if you have an increased risk for developing certain conditions or cancers.
The purpose of this study is train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features. Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.